N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a strong risk factor for poor prognosis and enables a more accurate appreciation of risk on top of the CHA2DS2‐VASc score in patients co‐morbid acute coronary syndrome and atrial fibrillation. This evidence concerns the gene NPPB and atrial fibrillation.